For older adults, the flu vaccine could look a little different this year.
The Food and Drug Administration just approved the new type of flu vaccine for adults ages 50 and older. It relies on the ...
Moderna’s newly approved vaccine could allow manufacturers to respond more rapidly to changing influenza strains.
The Food and Drug Administration has approved a new kind of flu vaccine for older people, the first made with the same mRNA ...
The first mRNA-based flu shot to be approved by the Food and Drug Administration will be ready for the upcoming flu season.
An mRNA-based flu (influenza) vaccine for adults 50 and over, Moderna’s mFLUSIVA, was approved by the U.S. Food and Drug Administration (FDA) on August 5. The approval offers older adults, who are at ...
The agency's former top vaccine regulator declined to review the Moderna shot, and it's now likely to face pushback from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results